Phase I/II study of nedaplatin, a cisplatin analogue, and S-1 in patients with advanced squamous cell lung carcinoma. - Phase I/II study of nedaplatin, a cisplatin analogue, and S-1 in patients with advanced squamous cell lung carcinoma.

Keio University School of Medicine, division of Pulmonary Medicine0 个研究点目标入组 45 人开始时间: 2010年3月15日最近更新: 2023年10月17日

试验速览

暂无简介。

•1.History of grave drug allergic reaction 2.Patients under treatment with phenytoin or flucytosine. 3.Serious complications (e.g. intestinal paralysis, intestinal obstruction, interstitial pneumonia or fibroid lung detectable on chest X-ray films , poorly controlled diabetes, heart failure, renal failure, hepatic failure, or haemorrhagic peptic ulcer etc.). Serious medical complications 4. History of poorly controlled pleural effusion,pericardial effusion and ascites . 5.Symptomatic brain metastasis 6.Patients with uncontrolled water diarrhea or chronic constipation. 7.Active double cancer. Carcinoma in situ and lesions of intramucosal carcinoma will not be included in active double cancer and will be permitted for registration. 8.Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. 9.Males that are currently attempting to produce a pregnancy. 10.Inadequate physical condition, as diagnosed by primary physician.

发起方

Keio University School of Medicine, division of Pulmonary Medicine